• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MCH-R1 拮抗剂 GPS18169,一种拟肽,是小鼠外周性抗肥胖药物。

MCH-R1 Antagonist GPS18169, a Pseudopeptide, Is a Peripheral Anti-Obesity Agent in Mice.

机构信息

Institut de Recherches Internationales Servier, 92284 Suresnes, France.

Genepep SA, 34430 Saint Jean de Vedas, France.

出版信息

Molecules. 2021 Feb 27;26(5):1291. doi: 10.3390/molecules26051291.

DOI:10.3390/molecules26051291
PMID:33673598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7957705/
Abstract

Melanin-concentrating hormone (MCH) is a 19 amino acid long peptide found in the brain of animals, including fishes, batrachians, and mammals. MCH is implicated in appetite and/or energy homeostasis. Antagonists at its receptor (MCH-R1) could be major tools (or ultimately drugs) to understand the mechanism of MCH action and to fight the obesity syndrome that is a worldwide societal health problem. Ever since the deorphanisation of the MCH receptor, we cloned, expressed, and characterized the receptor MCH-R1 and started a vast medicinal chemistry program aiming at the discovery of such usable compounds. In the present final work, we describe GPS18169, a pseudopeptide antagonist at the MCH-R1 receptor with an affinity in the nanomolar range and a Ki for its antagonistic effect in the 20 picomolar range. Its metabolic stability is rather ameliorated compared to its initial parent compound, the antagonist S38151. We tested it in an in vivo experiment using high diet mice. GPS18169 was found to be active in limiting the accumulation of adipose tissues and, correlatively, we observed a normalization of the insulin level in the treated animals, while no change in food or water consumption was observed.

摘要

黑色素浓缩激素(MCH)是一种在动物(包括鱼类、两栖类和哺乳动物)脑中发现的 19 个氨基酸长的肽。MCH 参与食欲和/或能量平衡。其受体(MCH-R1)的拮抗剂可能是理解 MCH 作用机制和对抗肥胖综合征的主要工具(或最终药物),肥胖综合征是一个全球性的社会健康问题。自从 MCH 受体的去孤儿化以来,我们克隆、表达并表征了受体 MCH-R1,并开始了一项广泛的药物化学计划,旨在发现这种可用的化合物。在本最终工作中,我们描述了 GPS18169,这是一种 MCH-R1 受体的假肽拮抗剂,其亲和力在纳摩尔范围内,其拮抗作用的 Ki 值在 20 皮摩尔范围内。与最初的母体化合物 S38151 相比,其代谢稳定性得到了相当的改善。我们在高脂肪饮食的小鼠体内实验中对其进行了测试。GPS18169 被发现能够有效限制脂肪组织的积累,并且,我们观察到治疗动物的胰岛素水平正常化,而食物或水的消耗没有变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/b347f716654a/molecules-26-01291-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/94a92adb1a07/molecules-26-01291-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/d279d648da6e/molecules-26-01291-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/c7774f9886a6/molecules-26-01291-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/00c01f699c5a/molecules-26-01291-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/b347f716654a/molecules-26-01291-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/94a92adb1a07/molecules-26-01291-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/d279d648da6e/molecules-26-01291-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/c7774f9886a6/molecules-26-01291-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/00c01f699c5a/molecules-26-01291-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/832e/7957705/b347f716654a/molecules-26-01291-g005.jpg

相似文献

1
MCH-R1 Antagonist GPS18169, a Pseudopeptide, Is a Peripheral Anti-Obesity Agent in Mice.MCH-R1 拮抗剂 GPS18169,一种拟肽,是小鼠外周性抗肥胖药物。
Molecules. 2021 Feb 27;26(5):1291. doi: 10.3390/molecules26051291.
2
Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening.基于药效团的虚拟筛选鉴定新型黑色素浓缩激素受体-1拮抗剂小分子化学型。
Bioorg Med Chem Lett. 2019 Dec 15;29(24):126741. doi: 10.1016/j.bmcl.2019.126741. Epub 2019 Oct 16.
3
A novel and selective melanin-concentrating hormone receptor 1 antagonist ameliorates obesity and hepatic steatosis in diet-induced obese rodent models.一种新型选择性促黑素细胞激素受体1拮抗剂可改善饮食诱导的肥胖啮齿动物模型中的肥胖和肝脂肪变性。
Eur J Pharmacol. 2017 Feb 5;796:45-53. doi: 10.1016/j.ejphar.2016.12.018. Epub 2016 Dec 13.
4
Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics.双环烷基脲促黑素聚集激素受体拮抗剂的发现:口服有效的抗肥胖疗法。
J Med Chem. 2005 Apr 7;48(7):2274-7. doi: 10.1021/jm049035q.
5
Melanin-concentrating hormone 1-receptor antagonist suppresses body weight gain correlated with high receptor occupancy levels in diet-induced obesity mice.黑皮质素 1 型受体拮抗剂抑制饮食诱导肥胖小鼠体重增加,与其受体占有率水平相关。
Eur J Pharmacol. 2009 Dec 10;624(1-3):77-83. doi: 10.1016/j.ejphar.2009.10.004. Epub 2009 Oct 18.
6
Solid-phase synthesis and structure-activity relationships of novel biarylethers as melanin-concentrating hormone receptor-1 antagonists.新型联芳醚作为促黑素聚集激素受体-1拮抗剂的固相合成及构效关系
Bioorg Med Chem Lett. 2006 Oct 1;16(19):5066-72. doi: 10.1016/j.bmcl.2006.07.040. Epub 2006 Aug 1.
7
Discovery of a novel series of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.发现一系列新型黑色素聚集激素受体 1 拮抗剂,可用于治疗肥胖症。
Bioorg Med Chem Lett. 2011 Dec 1;21(23):7001-5. doi: 10.1016/j.bmcl.2011.09.110. Epub 2011 Oct 5.
8
Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists.作为促黑素聚集激素受体1拮抗剂的口服有效苯并咪唑类化合物的设计与合成
Bioorg Med Chem Lett. 2006 Jul 15;16(14):3674-8. doi: 10.1016/j.bmcl.2006.04.062. Epub 2006 May 11.
9
Tetrahydrocarboline analogs as MCH-1 antagonists.四氢咔啉类似物作为 MCH-1 拮抗剂。
Bioorg Med Chem Lett. 2010 Dec 1;20(23):7024-8. doi: 10.1016/j.bmcl.2010.09.122. Epub 2010 Sep 29.
10
Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.发现1,3-二取代-1H-吡咯衍生物作为强效促黑素细胞激素受体1(MCH-R1)拮抗剂。
Bioorg Med Chem Lett. 2008 Sep 1;18(17):4859-63. doi: 10.1016/j.bmcl.2008.07.079. Epub 2008 Jul 24.

引用本文的文献

1
Pharmacotherapy for chronic obesity management: a look into the future.慢性肥胖管理的药物治疗:展望未来。
Intern Emerg Med. 2023 Jun;18(4):1019-1030. doi: 10.1007/s11739-023-03237-4. Epub 2023 May 30.
2
The melanin-concentrating hormone system as a target for the treatment of sleep disorders.作为睡眠障碍治疗靶点的促黑素细胞激素系统。
Front Neurosci. 2022 Sep 13;16:952275. doi: 10.3389/fnins.2022.952275. eCollection 2022.

本文引用的文献

1
Control of Adipose Cell Browning and Its Therapeutic Potential.脂肪细胞褐色化的调控及其治疗潜力
Metabolites. 2020 Nov 19;10(11):471. doi: 10.3390/metabo10110471.
2
Adipose Tissue Lipokines: Recent Progress and Future Directions.脂肪组织脂素:最新进展与未来方向。
Diabetes. 2020 Dec;69(12):2541-2548. doi: 10.2337/dbi20-0012.
3
Sleep-Wake Control by Melanin-Concentrating Hormone (MCH) Neurons: a Review of Recent Findings.黑皮质素神经元对睡眠-觉醒的控制:近期研究结果综述。
Curr Neurol Neurosci Rep. 2020 Oct 2;20(12):55. doi: 10.1007/s11910-020-01075-x.
4
Nutrition, Bioenergetics, and Metabolic Syndrome.营养、生物能量学与代谢综合征
Nutrients. 2020 Sep 11;12(9):2785. doi: 10.3390/nu12092785.
5
Body Mass Index and Prognosis of COVID-19 Infection. A Systematic Review.体重指数与新型冠状病毒肺炎感染的预后:一项系统评价
Front Endocrinol (Lausanne). 2020 Aug 14;11:562. doi: 10.3389/fendo.2020.00562. eCollection 2020.
6
Effectiveness of Individual Real-Time Video Counseling on Smoking, Nutrition, Alcohol, Physical Activity, and Obesity Health Risks: Systematic Review.个体实时视频咨询对吸烟、营养、饮酒、身体活动和肥胖健康风险的影响:系统评价。
J Med Internet Res. 2020 Sep 11;22(9):e18621. doi: 10.2196/18621.
7
Effects of atazanavir, darunavir, and raltegravir on fat and muscle among persons living with HIV.阿扎那韦、达芦那韦和雷特格韦对 HIV 感染者体内脂肪和肌肉的影响。
HIV Res Clin Pract. 2020 Aug;21(4):91-98. doi: 10.1080/25787489.2020.1809807. Epub 2020 Sep 3.
8
Pharmacological treatment strategies for patients with monogenic obesity.单基因肥胖患者的药物治疗策略
J Pediatr Endocrinol Metab. 2020 Jul 3. doi: 10.1515/jpem-2020-0129.
9
Role of melanin-concentrating hormone in drug use disorders.黑皮质素浓缩激素在药物使用障碍中的作用。
Brain Res. 2020 Aug 15;1741:146872. doi: 10.1016/j.brainres.2020.146872. Epub 2020 May 1.
10
Relative leptin deficiency in children with severe early-onset obesity (SEOO) - results of the Early-onset Obesity and Leptin - German-Polish Study (EOL-GPS).重度早发性肥胖(SEOO)儿童的相对瘦素缺乏——早发性肥胖与瘦素德国-波兰研究(EOL-GPS)的结果
J Pediatr Endocrinol Metab. 2020 Feb 25;33(2):255-263. doi: 10.1515/jpem-2019-0469.